New diagnostic criteria for the behavioural variant of frontotemporal dementia

European Neurological Review

Volumn 6, Issue 4, 2011, Pages 234-237

  Pijnenburg, Yolande A L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clinical; Diagnosis; Frontotemporal dementia; Pathology; Sensitivity

Indexed keywords

EID: 84858271761     PISSN: 17583837     EISSN: 17583845     Source Type: Journal    
DOI: 10.17925/ENR.2011.06.04.234     Document Type: Article

References (31)

1. Alzheimer A, [On certain peculiar diseases of old age], Zeitschrift für die gesamte Neurologie und Psychiatrie (Berlin),1911;4:356-85.
2. Pick A, [On the relations of senile brain atrophy to aphasia],Prager Medizinische Wochenschrift, 1892;15:165-7.
3. Cairns NJ, Bigio EH, Mackenzie IR, et al., Neuropathologicdiagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration, Acta Neuropathol, 2007;114:5-22.
4. Rohrer JD, Lashley T, Schott JM, et al., Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration, Brain, 2011;134:2565-81.
5. Snowden JS, Thompson JC, Stopford CL, et al., The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships, Brain, 2011;134:2478-92.
6. Mackenzie IR, Neumann M, Bigio EH, et al., Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update, Acta Neuropathol, 2010;119:1-4.
7. Poorkaj P, Bird TD, Wijsman E, et al., Tau is a candidate gene for chromosome 17 frontotemporal dementia, Ann Neurol, 1998;43:815-25.
8. Baker M, Mackenzie IR, Pickering-Brown SM, et al., Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17, Nature, 2006;442:916-9.
9. Cruts M, Gijselinck I, van der Zee J, et al., Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21, Nature, 2006;442:920-4.
10. Dejesus-Hernandez M, Mackenzie IR, Boeve BF, et al., Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS, Neuron, 2011;72:245-56.
11. Renton AE, Majounie E, Waite A, et al., A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-Linked ALS-FTD, Neuron, 2011;72:257-68.
12. Brun A, Frontal lobe degeneration of non-Alzheimer type. I. neuropathology, Arch Gerontol Geriatr, 1987;6:193-208.
13. Gustafson L, Frontal lobe degeneration of non-Alzheimer type II. Clinical picture and differential diagnosis, Arch Gerontol Geriatr, 1987;6:209-23.
14. Neary D, Snowden JS, Northen B, Goulding P, Dementia of frontal lobe type, J Neurol Neurosurg Psychiatry, 1988;51:353-61.
15. The Lund and Manchester Groups, Clinical and neuropathological criteria for frontotemporal dementia, J Neurol Neurosurg Psychiatry, 1994;57:416-8.
16. Neary D, Snowden JS, Gustafson L, et al., Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria, Neurology, 1998;51:1546-54.
17. Rascovsky K, Hodges JR, Kipps CM, et al., Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): Current limitations and future directions, Alzheimer Dis Assoc Disord, 2007;21:S14-8.
18. Rascovsky K, Hodges JR, Knopman D, et al., Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia, Brain, 2011;134(Pt 9):2456-77.
19. Knopman DS, Boeve BF, Parisi JE, et al., Antemortem diagnosis of frontotemporal lobar degeneration, Ann Neurol, 2005;57:480-8.
20. Mendez MF, Shapira JS, McMurtray A, et al., Accuracy of the clinical evaluation for frontotemporal dementia, Arch Neurol, 2007;64:830-5.
21. Piguet O, Hornberger M, Shelley BP, et al., Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia, Neurology, 2009;72:732-7.
22. Pijnenburg YAL, Mulder JL, Van Swieten JC, et al., Diagnostic accuracy of consensus diagnostic criteria for frontotemporal dementia in a memory clinic population, Dement Geriatr Cogn Disord, 2008;25:157-64.
23. Davies RR, Kipps CM, Mitchell J, et al., Progression in frontotemporal dementia - Identifying a benign Behavioral variant by magnetic resonance imaging, Arch Neurol, 2006;63:1627-31.
24. Hornberger M, Shelley BP, Kipps CM, et al., Can progressive and non-progressive behavioural variant frontotemporal dementia be distinguished at presentation?, J Neurol Neurosurg Psychiatry, 2009;80:591-3.
25. Kipps CM, Hodges JR, Fryer TD, Nestor PJ, Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype, Brain, 2009;132:2566-78.
26. Koedam EL, Van der Flier WM, Barkhof F, et al., Clinical characteristics of patients with frontotemporal dementia with and without lobar atrophy on MRI, Alzheimer Dis Assoc Disord, 2010;24:242-7.
27. Vandenberghe R, Sense and sensitivity of novel criteria for frontotemporal dementia, Brain, 2011;134:2450-3.
28. Rascovsky K, Hodges JR, Knopman D, et al., Sensitivity of Diagnostic Criteria in Autopsy-Confirmed Patients with Behavioral Variant Frontotemporal Dementia (bvFTD): First Report of the International bvFTD Criteria Consortium (FTDC), Neurology, 2011;76:A262-3.
29. Roman GC, Tatemichi TK, Erkinjuntti T, et al., Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop, Neurology, 1993;43:250-60.
30. McKeith IG, Dickson DW, Lowe J, et al., Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium, Neurology, 2005;65:1863-72.
31. McKhann GM, Knopman DS, Chertkow H, et al., The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging- Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, 2011;7:263-9.